Compounds > 2-amino-5-phosphonovalerate
Page last updated: 2024-10-21

2-amino-5-phosphonovalerate and Inadequate Sleep

2-amino-5-phosphonovalerate has been researched along with Inadequate Sleep in 1 studies

2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Monti, JM1
Jantos, H1
Catenaccio, V1
Xavier, S1

Other Studies

1 other study available for 2-amino-5-phosphonovalerate and Inadequate Sleep

ArticleYear
Blockade of the NMDA and AMPA/kainate receptors in the dorsal raphe nucleus prevents the 5-HT₃ receptor agonist m-chlorophenylbiguanide-induced suppression of REM sleep in the rat.
    Progress in neuro-psychopharmacology & biological psychiatry, 2011, Jul-01, Volume: 35, Issue:5

    Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-

2011